title: Comment on: Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia.
authors.affiliation: Infectious Disease Control, Department of Pharmacy, Hospital Universitari del Mar, Passeig Marítim 25-29, E-08003 Barcelona, Spain Hospital del Mar Medical Research Institute (IMIM), Hospital Universitari del Mar, Passeig Marítim 25-29, E-08003 Barcelona, Spain dconde@hospitaldelmar.cat.
authors.forename: David
authors.initials: D
authors.lastname: Conde-Estévez
authors.affiliation: Infectious Disease Control, Department of Pharmacy, Hospital Universitari del Mar, Passeig Marítim 25-29, E-08003 Barcelona, Spain Universitat Autònoma de Barcelona, Passeig Marítim 25-29, E-08003 Barcelona, Spain.
authors.forename: Santiago
authors.initials: S
authors.lastname: Grau
mesh_terms: D000667:Ampicillin / Q000627:therapeutic use*; D013293:Enterococcus faecalis / Q000187:drug effects*; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000401:mortality*; D006801:Humans; D008297:Male; D014640:Vancomycin / Q000627:therapeutic use*
chemical_list: D014640:Vancomycin; D000667:Ampicillin
keywords: ampicillin; healthcare-associated bacteraemia; vancomycin